1989
DOI: 10.1093/ajhp/46.7.1389
|View full text |Cite
|
Sign up to set email alerts
|

Justification and implementation of a cancer center pharmacy satellite

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1999
1999
2008
2008

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…Novel techniques that increased the robustness of the chemotherapeutic medication preparation process were also proposed. Last, the present study leveraged the research of Sauer and colleagues, which suggested the use of satellite hematology/oncology pharmacies in error reduction and increased patient care (Sauer, Nowak, Coons, Parr, & McIntyre, 1989). Such pharmacies have been associated with a reduction in turnaround time (and accordingly, patient wait time) versus a central setting, a reduction in missing medications, and fewer medication order discrepancies.…”
Section: Review Of the Literaturementioning
confidence: 85%
“…Novel techniques that increased the robustness of the chemotherapeutic medication preparation process were also proposed. Last, the present study leveraged the research of Sauer and colleagues, which suggested the use of satellite hematology/oncology pharmacies in error reduction and increased patient care (Sauer, Nowak, Coons, Parr, & McIntyre, 1989). Such pharmacies have been associated with a reduction in turnaround time (and accordingly, patient wait time) versus a central setting, a reduction in missing medications, and fewer medication order discrepancies.…”
Section: Review Of the Literaturementioning
confidence: 85%
“…This kind of evaluation is rarely seen in the literature or is limited to the economic benefits brought by centralization. [12][13][14][15][16][17][18][19] Moreover, the impact of a pharmaceutical intervention in the circuit of therapeutical agents has already been measured at the level of costs, charges, and lengths of stay, but not in a circuit of injectable cytotoxic drugs. 20,21 We demonstrated that the addition of a pharmacist to the circuit improves the quality and safety of chemotherapy; however, we do not know whether this addition affects clinical outcomes (decreased infection rate, etc.)…”
Section: Discussionmentioning
confidence: 99%